We propose a hierarchical Bayesian methodology to model spatially or spatio-temporal clustered survival data with possibility of cure. A flexible continuous transformation class of survival curves indexed by a single parameter is used. This transformation model is a larger class of models containing two special cases of the well-known existing models: the proportional hazard and the proportional odds models. The survival curve is modeled as a function of a baseline cumulative distribution function, cure rates, and spatio-temporal frailties. The cure rates are modeled through a covariate link specification and the spatial frailties are specified using a conditionally autoregressive model with time-varying parameters resulting in a spatio-temporal formulation. The likelihood function is formulated assuming that the single parameter controlling the transformation is unknown and full conditional distributions are derived. A model with a non-parametric baseline cumulative distribution function is implemented and a Markov chain Monte Carlo algorithm is specified to obtain the usual posterior estimates, smoothed by regional level maps of spatiotemporal frailties and cure rates. Finally, we apply our methodology to melanoma cancer survival times for patients diagnosed in the state of New Jersey between 2000 and 2007, and with follow-up time until 2007.
Introduction
Survival curves are modeled with a pre-specified functional form which is built on a set of assumptions that are sometimes difficult to verify a priori. One of the most popular models in survival analysis is the Cox proportional hazard (PH) model, 1, 2 which assumes PHs across two sets of covariates. When the proportionality assumption does not hold, a generalized PH framework or a proportional odds (PO) model 3 is usually considered. The generalized PH model assumes that the proportional effect on the hazard function may be time varying, while the PO model adopts a time constant odds ratio between two sets of covariates.
Research addressing situations when the assumptions for the PH and PO models are violated exists in the literature. 5, 4 For example, a linear transformation is proposed by Cheng et al. 5 Let T be the time to event, X the covariate vector, and the corresponding regression parameter, then the linear transformation is given by equation (1), where h(.) is a strictly increasing function and S(tjX) the survival function of t given the covariate X. If (y) ¼ log[Àlog(y)], the linear transformation reduces to the PH model, and when (y) ¼ À logit (y), equation (1) corresponds to the PO model
Model 1 assumes that all the subjects at risk will eventually experience the event of interest after a sufficiently long follow-up time. However, survival curves that flatten out at a value greater than zero are commonly observed in many areas including cancer survival times and epidemiological studies. A well-pronounced plateau is considered as evidence of the existence of a proportion of subjects for whom the event of interest will never occur. When analyzing time to event data, this proportion of patients is called cure rate. The most popular type of survival model incorporating this assumption is the mixture model. 6 The mixture cure rate survival model formulates a population survival curve based on a latent random variable Y that controls the cure process, Y ¼ 1 indicates cure with probability , otherwise Y ¼ 0. Given Y ¼ 0, T's are independently distributed f(tjX), with corresponding survival function S(tjX). Then, marginalizing over Y, the population survival mixture model, S p (tjX), is given by equation (2) .
where is the cure fraction and S(tjX) is a proper survival function for the susceptible individuals in the sense that lim t!1 S(tjX) ¼ 0. Cure rate modeling has been studied in both frequentist [7] [8] [9] and Bayesian 10-12 setups, and it has been extended in ways that facilitate biomedical interpretation of the cure process. 11, 12 Model 1 also assumes that the survival times are independent, but in many applications the independence assumption may not be satisfied. Dependent survival times arise from clustering effects. For example, in cancer research, observations within the same county and year of diagnosis may be correlated. A frailty or random effect model accounts for correlation. It formulates the nature of the underlaying dependence through a covariance specification and then the survival times are assumed to be independent conditionally on the unobserved frailty. Clayton 13 uses a gamma frailty survival model without covariates, although this frailty model incorporates heterogeneity among clusters, it does not consider spatial or temporal correlations. Although spatial frailty models have been mainly used in other contexts, such as disease mapping, [14] [15] [16] Banerjee and Dey 17 model survival data accounting for spatial correlation and have shown that misleading results could be obtained using traditional non-spatial models when data exhibit a spatial structure. Conditionally autoregressive (CAR) models are the most popular areal models in the spatial literature. [18] [19] [20] Given a map, they model a correlation structure for the locations based on neighboring information.
It has been shown in the literature the need to model spatio-temporal clustered lifetime data with a flexible methodology, beyond the traditional cure rate PH model, yet there is not methodology that comprehensibility integrates all these assumptions. In this article, we propose a model for spatio-temporally arranged survival data that integrates cure rates and a flexible transformation.
We do not assume any proportionality of the survival curve, instead we use a single parameter based transformation on S p (tj.). The benchmark PH and PO models are special cases of our transformation model. Here, S p (tj.) is modeled as a function of a baseline cumulative distribution function (cdf), cure rates, and spatio-temporal frailties. The likelihood function is formulated assuming that the single parameter controlling the transformation is unknown (it needs to be estimated) and full conditional distributions are derived. A Markov chain Monte Carlo (MCMC) procedure is proposed for Bayesian estimation of the single parameter that controls the transformation, cure rates and spatio-temporal frailty parameters.
The format of this article is as follows. Section 2 introduces our transformation class of spatiotemporal cure rate survival models and its properties. Section 3 describes the likelihood formulation, posterior properties and Bayesian modeling, including model diagnosis and the description of the MCMC technique used. Section 4 is dedicated to the Bayesian analysis of a melanoma cancer data set from the Surveillance, Epidemiology and End Results (SEER) database. Finally, conclusions and discussion points are presented in Section 5.
The model 2.1 Motivation and general formulation
Assume that the cure process for a particular subject is determined by N, the number of latent competing risks 12 (i.e. carcinogenic cells left active after a treatment phase) and Y 1 , Y 2 , . . . Y N , the latent competing risks (i.e. the incubation times for each carcinogenic cell). Each N is assumed to have a probability mass function P (N ¼ n) and Y 1 , Y 2 , . . . Y N are assumed to be independent and identically distributed (iid) with common survival function S(y) ¼ 1 À F 0 (y). The time to event, T, (i.e. time to death due to colon cancer) is defined by
Assuming that N is independent of Y i 8 i , the survival function for T is given by S p ðtÞ ¼ P 1 n¼0 PðY 1 4 t, . . . , Y n 4 tjN ¼ nÞP ðN ¼ nÞ, which reduces to
where M (.) is the moment generating function of Nj. For example, if Nj $ Poisson(), then S p (t) ¼ exp[ÀF 0 (t)] which is the model proposed by Chen et al. 12 Clearly, S p (t) ¼ exp[ÀF 0 (t)] yields to a PH structure and the cure fraction is given by exp(). There is also a mathematical relationship between models 3 and 2. Assuming that N ¼ 0 with probability and N ¼ 1 with probability 1 À , model 3 reduces to the mixture cure rate model 6 given by equation (2). A more general transformation for M (ln[1 À F 0 (t)]) in equation (3) can be defined as
where () is a known monotone decreasing function on [0, 1], F 0 (t) is a proper CDF such that F 0 (0) ¼ 0 and F 0 (1) ¼ 1, and is the parameter that models the cure fraction. Because S p (1) ¼ () > 0, equation (4) is not a proper survival function and () is the cure rate. Since () is a monotone decreasing function on [0, 1], as ! 1, the cure fraction () ! 0 while as ! 0, the cure fraction () ! 1.
The corresponding population density and hazard functions are, respectively, given by f p (t) ¼ À 0 [F 0 (t)]f(t) and h p ðtÞ ¼ À The transformation class of models given by equation (4) is a broader family of cure rate models, for example, consider a Box-Cox type of transformation 10 indexed by a unique parameter 2 [0, 1) like the one shown in equation (5) . Note that lim !0 ð1 þ xÞ À 1 ¼ exp ðÀxÞ, additionally when ¼ 1, equation (5) has a PO structure model, while ¼ 0 is a PH model. A transformation class of models given by equations (4) and (5) is a rich family of models beyond the traditional PO and PH models
The model defined by equations (4) and (5) is identifiable under the conditions listed in Theorem 2.1. Consider the class of models of the form: (1) If is assumed to be known and F(t) F(tj), where is a parameter or vector of parameters, the model S p (tjz) ¼ [F(t)(z)], t < C is identifiable for all (z) (unspecified or specified by any link function). (2) If is assumed to be known and F(t) is unspecified (i.e. modeled non-parametrically), the model
(unspecified or parametrically specified).
Model extension for spatio-temporal clustered survival data
We extend the model given by equations (4) and (5) to a spatio-temporal clustered survival setting. Assume that there are n jk subjects located at the jth region who were diagnosed in the kth year where j ¼ 1, . . . , J and k ¼ 1, . . . , K. The observed response is t ijk ¼ min{T ijk , C ijk }, where T ijk is the survival time for the ith subject located at the jth region who was diagnosed in the kth year for i ¼ 1, . . . , n jk and C ijk the censoring variable. Suppose we observe for the ijk individual a L Â 1 vector of covariates Z ijk and that the baseline CDF F 0 (.) F 0j for j ¼ 1, . . . , J (i.e. the baseline CDF's are spatially dependent).
Using the general class of transformation discussed in Section 2.1, the population survival curve with spatio-temporal frailties and cure rates is given by equation (6)
where () is given by equation (5), w jk is the spatio-temporal frailty terms, and (, Z ijk ) is an increasing positive link function that models the cure fraction. Since S p (1) ¼ [(, Z ijk ) exp (w jk )] and (, Z) is an increasing positive link function, we can interpret the role of the regression coefficients in the cure fraction. A large negative regression coefficient leads to a small value of which implies a larger cure fraction when the covariates are positive. When ¼ 0, the population survival function reduces to equation (7) which is an extension of the cure rate PH model 12 to a spatio-temporal survival model with cure fraction. The cure fraction from equation (7) is given by
If ¼ 1, equation (6) reduces to equation (8) which is a spatio-temporal PO survival model with cure fraction where S p (1)
The parameters that control the cure process, (), and the spatio-temporal frailties, w jk , are modeled through a hierarchical specification. The cure rates are controlled by the positive increasing link function, (, Z ijk ). Although many link functions can be used, we model (,
. Some authors 9 have worked with the exponential link function given by equation (9) . One advantage of the exponential link is that it can be interpreted in the context of a canonical link for a Poisson regression model. 12 We prove that a model with exponential link function is identifiable under different setups (Theorems 2.1 and 3.1).
To capture the spatio-temporal relationships, we introduced the random effects w jk in equation 6. Let us define W k ¼ (w 1k , . . . , w Jk ) 0 as the frailty for the kth year. In the absence of spatial correlation, the elements of W k are modeled as iid random variables for all k. However, here, we allow {w 1k , . . . , w Jk } to be spatially correlated across the regions with a suitable prior specification for each k. Under the assumption of spatial correlation among regions, the distribution for the frailty for the kth year needs to reflect this structure. A popular choice is the CAR distribution. 20 We assume that W k have a CAR distribution with parameters ð, 2 k Þ. To define this, consider that the J Â 1 vector of spatial frailties for the kth year is assumed to have a multivariate normal distribution. Let M ¼ {m jj 0} be the adjacency matrix of the graph of the geographical region, i.e. let m jj 0 ¼ 1, if the jth and j 0 th counties are neighbors and 0 otherwise. Define m j+ ¼ P b m jb , the number of neighbors for the jth county and D M ¼ Diag{m j+ }. Assume that 0 < < 1 is a smoothing parameter, which can be viewed as a measure of spatial association in the sense that Covðw jk ,
Furthermore, the vectors of spatial frailties W k , for k ¼ 1, . . . K, are assumed to be correlated through a prior specification for 2 k . In this section, we have derived a transformation class of cure rate models, listed its properties and extended to a spatio-temporal clustered survival setting. We also presented the conditions for the model to be identifiable. In the following section, we propose a Bayesian estimation methodology and study the properties of the posterior distribution.
Bayesian estimation 3.1 Likelihood, posterior distribution, and properties
Bayesian inference provides a viable alternative to jointly estimate the transformation parameter , the spatio-temporal frailties w jk , and the cure rate related parameters . We fit the model in a Bayesian setting for right censored data as follows:
Since 0 ðxÞ ðxÞ ¼ Àð1 þ xÞ À1 1If 4 0g, equation (11) reduces to equation (12) for 2 (0, +1). The likelihood construction for the case when ¼ 0 is given in Appendix 2.
We assume that the variables T ijk and C ijk are conditionally independent given z ijk . We also assume that the observations in the same spatio-temporal cluster jk are dependent but exchangeable.
, and assume that 0 < < 1, k > 0 8 k , all the priors are independent and that the prior of is proper. Then, the joint posterior distribution of (, c, F 0 ) based on D is given by
where (), (), and (F 0 ) are the priors of , , and F 0 , respectively, and ½W k j, 2 k given by equation (10) . Prior to drawn inferences, we investigate the posterior properties of equation (13) . The posterior propriety under an improper prior for established in Theorem 3.1 implies that under certain conditions for F 0 the model is identifiable and the estimation of the regression coefficients that control the cure rates can contain little subjective information. The proof of Theorem 3.1 is given in Appendix 3.
Condition (a) of Theorem 3.1 is frequently required in many regression setups and commonly satisfied by many data sets. Condition (b) indicates that we need some prior information about the parameter which can be easily elicited. Condition (c) ensures a CAR model for the spatiotemporal frailties W. Finally, condition (d) is a more technical condition but not as restrictive as it seems. Some parametric specifications for F 0 satisfy condition (d), for example, if the baseline CDF is based on the exponential () model, F 0 (t) F 0 (tj), 1 < < 1. It can be shown that there exists a constant R > 0 such that f 0 ðtÞ F 0 ðtÞ ¼ e exp fÀe tg 1Àexp fÀe tg 5 R 8 t > e > 0. Additionally, for a Weibull distribution with parameters (z, ), it can be shown that f 0 ðtÞ F 0 ðtÞ ¼ t À1 e exp fÀe t g 1Àexp fÀe t g R maxft À1 g, which under a proper hyperprior for z will led to a proper posterior under the conditions of Theorem 3.1. When F 0 is estimated non-parametrically, f 0j ðtÞ F 0j ðtÞ 5 R for some R > 0, for all j ¼ 1, . . . ,J and 0 < t < C guarantees a proper posterior even when () ! 1, but note that the conditions are sufficient but not necessary.
Model implementation: an example
To implement model (11) , we need to specify F 0 and priors and hyperpriors. In this particular section, we describe a model implementation with a non-parametric model for F 0 , and weakly informative but proper priors and hyperpriors for all the parameters.
We first turn our attention to the modeling of F 0j (t). We model F 0j (t) using a dense class of monotone transformations arising from mixture of beta distribution functions. 21 Since any continuous density in [0, 1] can be approximated as a discrete mixture of beta densities, 22 we consider the function J 0j ðtÞ ¼ a 0 F 0j ðtÞ a 0 F 0j ðtÞþb 0 which is increasing and maps [0, 1] into [0, 1], where a 0 > 0 and b 0 > 0. J 0j (t) can be modeled as a mixture of Beta(r e , s e ) CDFs as follows J 0j ðtÞ ¼ P E e¼1 ej IBðJ 0j ðtÞ; r e , s e Þ, where P E e¼1 ej ¼ 1; 8 j , IB(.; r e , s e ) denotes the incomplete beta function, and E, a 0 , b 0 ,J 0 ðtÞ, r e , and s e are fixed. F 0j (t) and f 0j (t) are then defined by 
The values of {(r e , s e )} are chosen such that the Beta(r e , s e ) CDF's have equally spaced means, and are centered aroundJ 0 ðtÞ.J 0 ðtÞ is chosen such thatJ 0j ðtÞ ¼ a 0F0j ðtÞ a 0F0j ðtÞþb 0 and a suitable hyper-prior is assigned toF 0j ðtÞ. E, a 0 , and b 0 are usually fixed.
The second modeling issue is the selection of the priors. We assume that c, q, and are independent and their components are also independent a priori. Specifically, we take c $ N L ð0, 2 c I L Þ, a normal distribution with mean zero and covariance matrix 2
a Dirichlet prior where 1 E is the unit vector of size E. To facilitate the interpretability of the parameters that control the cure rate, we restrict the parameter to [0, 1]. is then assumed to have a prior beta distribution, $ B(a , b ). The prior specification for each vector of frailties W k is given by equation (10) and W k j 2 k , , is assumed to be independent a prior 8 k . The hyperpriors for 2 ¼ ð 2 1 , . . . , 2 K Þ, and are assumed to independent a prior, and their components are also independent, such that 2 k $ IGða , b Þ, 8 k and $ B(a , b ).
To implement a Gibbs sampler with Metropolis-Hastings steps, we need to obtain all the conditional densities for the parameters , c, q, W, r, and . For j ¼ 1, . . . , J, k ¼ 1, . . . , K, the full conditional distribution functions are given as follows
where (Àj) represents all the vectors (i) , i 6 ¼ j, and W (Àk) all the vectors W (i) , i 6 ¼ k.
The proposed model (6) induces a flexible family of competing models for several modeling choices of F 0j (t), , and ; so, a model selection approach needs to be implemented. Model selection is a procedure to compare a class of competing models, and select the one that best fits the data. Our model selection is based on the conditional predictive ordinate (CPO) and deviance information criterion (DIC) measures.
The CPO 23 is extensively used in the literature. Large values of CPO ijk are indicators of a better fit. The sum of the logarithms of the pseudomarginal-likelihood (LPML) measures the goodness of fit and is given by LPML ¼ P i,j,k log CPO ijk , where large values indicate better fit. LPML is a welldefined statistics as long as the posterior density is proper, so it is possible to find it even when the prior distribution is improper. It is easy to compute from the MCMC samples and it is computationally stable. The DIC 24 is a penalized likelihood criteria, such as the Akaike information criterion. The DIC is based on the posterior distribution of the deviance statistics and it is defined as DIC ¼ Dev þ p Dev , where Dev is the posterior mean of the deviance and p Dev a penalty term for model complexity and depends on the total number of model parameters.
Application
We illustrate our methodology with a melanoma cancer data set from the National Cancer Institute SEER database. 25 The cohort extracted is a population of 10,337 subjects who were diagnosed with melanoma cancer in one of the counties of the state of New Jersey between 2000 and 2007 and had been undergoing treatment since diagnosis. In the state of New Jersey, hospitals, physicians, and laboratories located in all counties are required to report primary cancer cases along with clinical, temporal, and geographical variables. All the cases are followed annually and vital status is recorded. For deceased cases, the underlying cause of death is also included. One of the goals of New Jersey registry is to describe cancer patterns in the state to adopt programs and services that increase survival and identify risk factors. The lifetimes here are naturally clustered by region (counties) and year of diagnosis and inferences about survival curves and cure rates can be used by health care providers, public health officials, and administrators to adopt new programs, educational campaigns, and services.
All the subjects were diagnosed with only melanoma cancer and were followed up since diagnosis until December 2007. Subjects who have died due to melanoma cancer were considered failed and the rest (those who die due to other causes, drop out, or survive until the end of the study) were considered censored. By the end of 2007, 1480 patients have died of melanoma cancer (14%) while the remaining were censored.
The variables considered in this analysis are lifetime in months since diagnosis, year of diagnosis, and county of residence while undergoing treatment (Table 1) . Subjects who moved during the treatment phase were removed from the data set. The patient level covariates included were: gender, race (white, black, or other), age, stage of the disease (local, regional, or distant), radiation therapy (whether or not the patient received radiation therapy), surgery (whether or not the patient received surgery), marital status (married or divorced, separated, widowed, single), and median family income on the county of residence (in thousands). A clinical interaction of interest is the interaction between radiation and stage since radiation is a treatment used mainly for melanoma patients whose stage at diagnosis is not local. It is also known that surgery is the first course of action for melanoma treatment, so it may be of interest to analyze if radiation and surgery interact.
The marginal estimated Kaplan-Meier curves for all the counties in the state of New Jersey show a plateau in the survival curve (see, for example, Figure 1 ), thus a cure rate model appears to be suitable for these data. Kaplan-Meier curves also show regional differences on the survival curve which can be explained using spatially correlated frailties. Survival curves over a long period of time are usually not time invariant so temporal components should be included. Additionally, the Kaplan-Meier curves evidence that non-proportionality of hazard occurs with (possibly strong) between-county survival difference including crossing of survival curves over time. Proportionality of the hazard functions is a strong assumption for these data.
The characteristics of the above-mentioned data violate the assumptions of many classical survival models. Classical survival models often consider that all the subjects are at risk of death, non-spatio-temporal clusters, and either proportionality of the hazard or the survival odds when covariates are present.
This section has two goals. First, we model our data using the transformation class spatiotemporal cure rate model in equation (6) with non-parametric baseline given by equation (14) (full model). We carry out a Bayesian analysis with covariates using the proposed priors and obtain the usual posterior estimates, smoothed by county level maps of spatio-temporal frailties and cure rate parameters. Second, we compare the full model with the standard PH ( ¼ 1) and PO ( ¼ 0) cure rate models with iid frailties ( ¼ 0) and spatio-temporal frailties.
The Gibbs sampler with Metropolis-Hastings steps described in Section 3.2 was implemented. For some parameters, transformations were necessary and the hyperparameters for the prior distributions were chosen to obtain flat distributions. We coded the algorithm in R. 26 The modeling constants E, fðr e , s e Þg E e¼1 ,J 0j ðtÞ, a 0 , and b 0 in equation (14) were chosen as follows. Based on Gelfand and Mallick, 21 we fixed E ¼ 5 since keeping E relatively small produces inferences that are almost indistinguishable from large E. fðr e , s e Þg E e¼1 where chosen to produce evenly spaced Beta CDFs by setting {r e } ¼ (1, 2, 3, 4, 5) and {s e } ¼ (5, 4, 3, 2, 1).F 0j ðtÞ, a 0 , and b 0 were selected such thatF 0j ðtÞ substantially maps into [0, 1].F 0j ðtÞ is a central distribution around which F 0j is distributed. The exponential distribution provides a flexible option in controlling the vagueness of the priors, so we setF 0j ðtÞ ¼ 1 À exp ð 0 tÞ; 8 j , a CDF from an exponential distribution with mean 1 0 , where 0 was fixed at 0.025 (corresponding to a large variance) which keeps our prior confidence about F 0j (t) vague. We found that choosing a 0 ¼ 100 0 and b 0 ¼ 400 led to values ofJ 0 ðtÞ ¼ a 0F0 ðtÞ
that substantially cover the interval [0, 1]. Our algorithm was ran three initially overdispersed parallel MCMC chains for 20.000 iterations each and 25% of the runs were used as burn in period. Convergence was assessed using autocorrelation plots, density plots, trace plots, acceptance rates, Heidelberger-Welch stationarity tests, and Gelman and Rubin's convergence diagnostic. 27, 28 The acceptance rate oscillates between 0.25 and 0.64. All the plots are satisfactory with the exception of some autocorrelation plots. Table 2 displays the posterior medians and 95% highest posterior density (HPD) intervals for the transformation parameter , the parameters involve in the cure rate specification ( [(, Z ijk )]) and the hyperparameters used in the modeling of the spatio-temporal frailties w jk . The estimates for the interaction between radiation and surgery are not displayed since they are not statistically significant; so, the model was refitted without this interaction. The posterior median for is 0.1565 with a 95% HPD of (0.149, 0.198) which indicates that the fitted model is neither a PO or PH model. According with the HPD intervals for the c parameters, all the variables involved in the cure rate specification are significant with the exception of the variables marital status and radiation; however, the interaction effect of radiation and stage of the tumor (local versus regional or distant) is statistically significant. The posterior median for the coefficient AGE is 0.8685 which implies that the cure rate decreases with age at diagnosis. For example, the odds of cure given one is diagnosed at age 25 over at age 45 are 1.37, assuming all other variables have zero effect. Similarly, any other overall cure odds for different age points can be computed using the formula [(, Z ijk )]. The cure rate increases as the median family income on the county of residence (in thousands) increases. Note that all the variables were standardized.
The posterior median for the variables gender and surgery are negative, indicating a higher cure rate effect for the female group and the patients that have a surgical procedure, respectively, while all the other variables are constant. The posterior median for the variable race is positive, indicating a higher cure rate effect for non-white group, while all the other variables are constant. The interaction between radiation and stage is significant. Table 3 presents the estimates of the overall interaction effects and summary statistics for the estimated cure rates stratified by stage at diagnosis and radiation therapy. The sign of the estimates is negative, indicating higher cure rates with respect to the baseline group (patients diagnosed with regional or distant tumor with no radiation treatment), while all the other variables are constant. The hyperparameters for the spatio-temporal components are all significant according to Table 2 . Especially, different from zero shows a spatial effect on the survival curve. The HPD intervals for the variables 2 k overlap which implies that the temporal effect may be not strong. Figure 2 shows a combination of a box plot and a kernel density plot for the estimated cure rates, ½ð, Z ijk Þ. The plot starts with a box plot. It then adds a rotated kernel density plot to each side of the box plot. The plots show the estimated cure rates classified by gender, race, surgery versus no surgery, and interaction between stage at diagnosis and radiation, respectively. All plots indicate low rates with high density around zero for the categories male, white, and no surgery, respectively. Patients in the group regional-distant stage tumor and no radiation have lower cure rate than those in any other classification of the radiation and stage interaction. The kernel is bimodal for the nonwhite category, indicating low cure rates for some non-white subjects and a higher proportion of non-white subjects with higher cure rates. Figure 5 . It shows the box plots of the posterior medians of the w jk frailties over time. Figure 5 suggests a constant trend for the first three years, followed by a decreasing trend for the last three years. The overall total decrease in median frailties from year 2000 to 2007 is 0.60 units over the observation period. We can also observe that the variability of the posterior medians changes over time.
We now compare several other models that belong to our family of proposed models using two criteria: LPML and DIC. Table 4 lists the DIC and LPML for models with random, fixed at two levels, and several frailty structures. Note that the frailties are assumed to be iid if ¼ 0, a model with CAR(, 2 ) structure is a model with spatial association, while a model with CARð, 2 k Þ is a model with spatio-temporal association. The cure rate PH CAR(, 2 ) model has the larger LPML statistics suggesting that the best model is the one with PH structure and spatial frailties. However, the best model according to the DIC criteria is the cure rate transformation model with random and CARð, 2 k Þ structure for the frailties suggesting a model with spatio-temporal frailties to be the best. For any transformation structure, cure rate models with spatial frailties and spatio-temporal frailties outperformed models with iid frailties.
The medians for the parameters involved in the cure rate specification (c) and the hyperparameters that control the spatio-temporal frailties (, 2 k ) for models with PH ( ¼ 0) and PO ( ¼ 1) structure are listed in Table 5 along with their 95% HPD intervals. The conclusions are consistent with the ones reached from Table 2 . All the variables involved in the cure rate specification are significant with the exception of marital status and education level. Additionally, the hyperparameters for the spatio-temporal components are all significant, in particular is different from zero (spatial frailty effect).
We have proposed a hierarchical Bayesian methodology to model spatially arranged survival data with possibility of cure and temporal effects. We propose a flexible transformation class of survival curves by assuming a continuous transformation of the population survival function indexed by a single parameter assumed to lie in [0, +1). Our transformation model is a larger class of models containing two special cases of the well-known existing models: PH and PO models. The survival curve is modeled as a function of a baseline curve, cure rates, and spatio-temporal frailties. Further, our model does not assume any particular shape for the baseline survival function, instead a non-parametric baseline function is incorporated. We integrate cure rates and spatiotemporal frailties into the survival curve specification. The cure rates are modeled through a covariate specification. The spatial frailties are specified using a CAR model with time-varying parameters resulting in a spatio-temporal formulation. The likelihood function is formulated assuming that the single parameter controlling the transformation is unknown (it needs to be estimated) and full conditional distributions are derived based on non-informative priors. Our melanoma survival example suggests that cure rate models with spatial or spatio-temporal frailties outperform cure rates models with iid frailties.
Discussion
We have formulated a class of models for spatially arranged survival data by simultaneously incorporating a cure fraction and adjusting for spatio-temporal correlation. The model formulation does not assume any proportionality of the survival curve, instead a single parameter based transformation on S p (tj.) was proposed. The benchmark PH and PO models are special cases of our transformation model. The model does not assume any particular shape for the baseline survival function, instead a non-parametric baseline function is incorporated. The cure rates are modeled through a covariate specification which allows for a biomedical interpretation and is suitable for Bayesian estimation. The spatial frailties are specified using a CAR model with timevarying parameters resulting in a spatio-temporal formulation. The likelihood function is formulated assuming that the single parameter controlling the transformation is unknown (it needs to be estimated) and full conditional distributions are derived based on quickly informative priors. We also considered several values of 2 [0, 1] to compare our model with the two benchmark models, PH and PO. Different values of led to a various modeling structures. The interpretation of c and {w jk } is the same for different transformations, but the effect on the cure rates, [(, Z ijk )], and spatio-temporal relative risks, [(, Z ijk )], is different, causing difficulties when comparison with PH or PO models is desired.
Our method is implemented via MCMC and it is naturally suitable for model comparison using the LPML and DIC criteria. An MCMC procedure was proposed for Bayesian estimation of the single parameter that controls the transformation, cure rates, and spatio-temporal frailties parameters. Another MCMC procedure was proposed when the parameter that control the transformation is assumed to be known. The computational efforts in terms of time and hardware are moderate, Table 5 . Parameter estimates and 95% HPD intervals for PH and PO models with ð, Z ijk Þ ¼ exp½ t ijk c and W jk $ CARð, 2 k ÞÞ.
especially for large samples like the one used here. We found some problems with some of the autocorrelation plots by, in general, the convergence diagnostics were satisfactory. Our results for the melanoma cancer data set support that a CAR prior and cure rates parameters can be useful in the modeling of the survival curves. The model formulation given by equation (6) supports many other specifications for (, Z ijk ) that lead to identifiable models as long as F(t) is parametrically specified (Theorems 2.1 and 3.1 ). Model (6) also supports other areal and geostatistical model specifications for the spatio-temporal frailties and it can be easily generalized to incorporate other random effects in addition to the random intercepts. Although our application does not include interaction effects in the cure rate specification, the model is suitable to include any kind of variables in the cure rate link function, (, Z ijk ).
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Integration out v, equation (20) reduces to
By assumption (d) of Theorem 3.1, f 0j ðt ijk l Þ F 0j ðt ijk l Þ 5 B for some B > 0, and so equation (21) is less than or equal that
